KARLIE NOVIAN: Open Payments
NPI 1285221721 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$692 in 23 payments from 12 companies in 2025. Trend: 2023 $20 · 2024 $13 · 2025 $692
Food & beverage: $692
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $325 |
| Blueprint Medicines Corporation | 3 | $89 |
| CSL Behring | 2 | $59 |
| Grifols USA, LLC | 1 | $35 |
| UCB, Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Bioventus LLC | 1 | $17 |
| SOBI, INC | 1 | $17 |
Products named: TEZSPIRE, AYVAKIT, Prolastin-C Liquid, Bimzelx, Andembry, OFEV, Hizentra, DUPIXENT.
Industry payments across TX — which companies pay providers there.
